NEU 3.32% $20.52 neuren pharmaceuticals limited

BP report, page-13

  1. 228 Posts.
    lightbulb Created with Sketch. 42
    2HCY16? "Trofinetide provides an opportunity potentially to be the first approved therapy for one or more of these important indications." You're having a laugh BP!

    Day 1:
    Trading Halt Regarding Results
    Day 3:
    Positive Results from Intrepid
    Day 4:
    Trading Halt Regarding Offer from Novartis
    Day 5:
    Trading Halt Regarding Counter Offer from Vertex
    AIMO

    Can't be long now, looking forward to the kickoff!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.52
Change
0.660(3.32%)
Mkt cap ! $2.622B
Open High Low Value Volume
$20.00 $20.66 $19.94 $6.431M 315.4K

Buyers (Bids)

No. Vol. Price($)
1 1024 $20.52
 

Sellers (Offers)

Price($) Vol. No.
$20.53 285 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.